Literature DB >> 19668609

Recommendations for neonatal surfactant therapy.

.   

Abstract

Year:  2005        PMID： 19668609      PMCID： PMC2722820     

Source DB:  PubMed          Journal:  Paediatr Child Health        ISSN： 1205-7088            Impact factor:   2.253


× No keyword cloud information.
  64 in total

1.  Early versus delayed neonatal administration of a synthetic surfactant--the judgment of OSIRIS. The OSIRIS Collaborative Group (open study of infants at high risk of or with respiratory insufficiency--the role of surfactant.

Authors: 
Journal:  Lancet       Date:  1992-12-05       Impact factor: 79.321

2.  Surfactant replacement therapy in high-risk congenital diaphragmatic hernia.

Authors:  A P Bos; D Tibboel; F W Hazebroek; J C Molenaar; B Lachmann; D Gommers
Journal:  Lancet       Date:  1991-11-16       Impact factor: 79.321

3.  Pathophysiology of congenital diaphragmatic hernia. III: Exogenous surfactant therapy for the high-risk neonate with CDH.

Authors:  P L Glick; C L Leach; G E Besner; E A Egan; F C Morin; A Malanowska-Kantoch; L K Robinson; A Brody; A S Lele; M McDonnell
Journal:  J Pediatr Surg       Date:  1992-07       Impact factor: 2.545

4.  Prenatal dexamethasone treatment in conjunction with rescue therapy of human surfactant: a randomized placebo-controlled multicenter study.

Authors:  M A Kari; M Hallman; M Eronen; K Teramo; M Virtanen; M Koivisto; R S Ikonen
Journal:  Pediatrics       Date:  1994-05       Impact factor: 7.124

5.  Multicentre randomised trial comparing high and low dose surfactant regimens for the treatment of respiratory distress syndrome (the Curosurf 4 trial).

Authors:  H L Halliday; W O Tarnow-Mordi; J D Corcoran; C C Patterson
Journal:  Arch Dis Child       Date:  1993-09       Impact factor: 3.791

6.  Surfactant replacement therapy in neonatal respiratory distress syndrome. A multi-centre, randomized clinical trial: comparison of high- versus low-dose of surfactant TA.

Authors:  M Konishi; T Fujiwara; T Naito; Y Takeuchi; Y Ogawa; K Inukai; M Fujimura; H Nakamura; T Hashimoto
Journal:  Eur J Pediatr       Date:  1988-01       Impact factor: 3.183

7.  Randomized study of nasal continuous positive airway pressure in the preterm infant with respiratory distress syndrome.

Authors:  J Tooley; M Dyke
Journal:  Acta Paediatr       Date:  2003-10       Impact factor: 2.299

8.  Surfactant replacement therapy for meconium aspiration syndrome.

Authors:  R D Findlay; H W Taeusch; F J Walther
Journal:  Pediatrics       Date:  1996-01       Impact factor: 7.124

9.  Nasal continuous positive airway pressure and early surfactant therapy for respiratory distress syndrome in newborns of less than 30 weeks' gestation.

Authors:  H Verder; P Albertsen; F Ebbesen; G Greisen; B Robertson; A Bertelsen; L Agertoft; B Djernes; E Nathan; J Reinholdt
Journal:  Pediatrics       Date:  1999-02       Impact factor: 7.124

10.  Double-blind, randomized trial of one versus three prophylactic doses of synthetic surfactant in 826 neonates weighing 700 to 1100 grams: effects on mortality rate. American Exosurf Neonatal Study Groups I and IIa.

Authors:  A Corbet; J Gerdes; W Long; E Avila; A Puri; A Rosenberg; K Edwards; L Cook
Journal:  J Pediatr       Date:  1995-06       Impact factor: 4.406
View more
  14 in total

1.  A role for community health care providers in neonatal follow-up.

Authors:  Sandra Woods; Patricia Riley
Journal:  Paediatr Child Health       Date:  2006-05       Impact factor: 2.253

2.  The use of equine surfactant and positive pressure ventilation to treat a premature alpaca cria with severe hypoventilation and hypercapnia.

Authors:  Stacy H Tinkler; Lindsey A Mathews; Anna M Firshman; Jane E Quandt
Journal:  Can Vet J       Date:  2015-04       Impact factor: 1.008

Review 3.  The use of surfactant in the neonatal period- the known aspects, those still under research and those which need to be investigated further.

Authors:  Nilgün Kültürsay; Özgün Uygur; Mehmet Yalaz
Journal:  Turk Pediatri Ars       Date:  2014-03-01

4.  Outcomes associated with surfactant in more mature and larger premature infants with respiratory distress syndrome.

Authors:  Wesley Jackson; Genevieve Taylor; Nicolas A Bamat; Kanecia Zimmerman; Reese Clark; Daniel K Benjamin; Matthew M Laughon; Rachel G Greenberg; Christoph P Hornik
Journal:  J Perinatol       Date:  2020-02-20       Impact factor: 2.521

5.  Assessment of surfactant use in preterm infants as a marker of neonatal intensive care unit quality.

Authors:  Heather C Kaplan; Scott A Lorch; Jennifer Pinto-Martin; Mary Putt; Jeffrey H Silber
Journal:  BMC Health Serv Res       Date:  2011-01-31       Impact factor: 2.655

6.  Advances in the management of meconium aspiration syndrome.

Authors:  Kamala Swarnam; Amuchou S Soraisham; Sindhu Sivanandan
Journal:  Int J Pediatr       Date:  2011-11-22

Review 7.  Exogenous surfactant therapy in 2013: what is next? Who, when and how should we treat newborn infants in the future?

Authors:  Emmanuel Lopez; Géraldine Gascoin; Cyril Flamant; Mona Merhi; Pierre Tourneux; Olivier Baud
Journal:  BMC Pediatr       Date:  2013-10-10       Impact factor: 2.125

8.  Deposition of Aerosolized Lucinactant in Nonhuman Primates.

Authors:  Timothy J Gregory; Hammad Irshad; Ramesh Chand; Philip J Kuehl
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2019-08-22       Impact factor: 2.849

9.  Minimally invasive surfactant therapy versus InSurE in preterm neonates of 28 to 34 weeks with respiratory distress syndrome on non-invasive positive pressure ventilation-a randomized controlled trial.

Authors:  Bhupendra Kumar Gupta; Anindya Kumar Saha; Suchandra Mukherjee; Bijan Saha
Journal:  Eur J Pediatr       Date:  2020-05-27       Impact factor: 3.183

10.  Characteristics and outcomes of preterm neonates according to number of doses of surfactant received.

Authors:  Hanita Coshal; Amit Mukerji; Brigitte Lemyre; Eugene H Ng; Ruben Alvaro; Guillaume Ethier; Eugene W Yoon; Marc Beltempo; Prakesh S Shah
Journal:  J Perinatol       Date:  2020-08-13       Impact factor: 2.521
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.